Mechanisms, prevalence and management of cardiac arrhythmias in cancer patients: a comprehensive review.
Francesco FloreRoberto ScacciavillaniGiulia IannacconeMaria Lucia NarducciGaetano PinnacchioGianluigi BencardinoFrancesco PernaFrancesco Raffaele SperaGianluca ComerciMassimiliano CamilliAntonella LombardoGaetano Antonio LanzaFilippo CreaGemma PelargonioPublished in: Future cardiology (2023)
Recently, prognosis and survival of cancer patients has improved due to progression and refinement of cancer therapies; however, cardiovascular sequelae in this population augmented and now represent the second cause of death in oncological patients. Initially, the main issue was represented by heart failure and coronary artery disease, but a growing body of evidence has now shed light on the increased arrhythmic risk of this population, atrial fibrillation being the most frequently encountered. Awareness of arrhythmic complications of cancer and its treatments may help oncologists and cardiologists to develop targeted approaches for the management of arrhythmias in this population. In this review, we provide an updated overview of the mechanisms triggering cardiac arrhythmias in cancer patients, their prevalence and management.
Keyphrases
- heart failure
- atrial fibrillation
- coronary artery disease
- risk factors
- papillary thyroid
- left ventricular
- congenital heart disease
- newly diagnosed
- ejection fraction
- percutaneous coronary intervention
- squamous cell carcinoma
- type diabetes
- prostate cancer
- cardiovascular disease
- palliative care
- left atrial
- catheter ablation
- cancer therapy
- acute coronary syndrome
- venous thromboembolism
- robot assisted
- patient reported
- direct oral anticoagulants
- cardiac resynchronization therapy
- aortic valve
- advanced cancer